Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Request a free trial

No credit card. No commitment.

Plans and Pricing

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: acyclovir

« Back to Dashboard
Acyclovir is the generic ingredient in six branded drugs marketed by Actavis Elizabeth, Apotex Inc, Cadila Pharms Ltd, Dava Pharms Inc, Heritage Pharms Inc, Ivax Sub Teva Pharms, Lek Pharm, Mylan, Ranbaxy, Roxane, Stason, Teva, Teva Pharms, Watson Labs, Delcor Asset, Valeant Bermuda, Amneal Pharms, Mylan Pharms Inc, Actavis Mid Atlantic, Hi Tech Pharma, Innocutis Holdings, Carlsbad, Hetero Labs Ltd V, Sun Pharm Inds Ltd, Zydus Pharms Usa Inc, Abbvie, Hikma Maple , Apothecon, Aurobindo Pharma Ltd, Bedford, Fresenius Kabi Usa, Hospira, Teva Parenteral, and Glaxosmithkline, and is included in fifty-nine NDAs. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

This ingredient has thirty-two patent family members in twenty-four countries.

There are fifty-four drug master file entries for acyclovir. Nine suppliers are listed for this compound.

Summary for Generic Name: acyclovir

Tradenames:6
Patents:6
Applicants:34
NDAs:59
Drug Master File Entries: see list54
Suppliers / Packaging: see list21
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details

Clinical Trials for: acyclovir

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Parenteral
ACYCLOVIR SODIUM
acyclovir sodium
INJECTABLE;INJECTION074969-002Aug 26, 1997DISCNNo<disabled><disabled>
Innocutis Holdings
SITAVIG
acyclovir
TABLET;BUCCAL203791-001Apr 12, 2013RXYes8,592,434<disabled>Y<disabled>
Stason
ACYCLOVIR
acyclovir
CAPSULE;ORAL075090-001Jan 26, 1999RXNo<disabled><disabled>
Teva Parenteral
ACYCLOVIR SODIUM
acyclovir sodium
INJECTABLE;INJECTION074969-001Aug 26, 1997DISCNNo<disabled><disabled>
Apothecon
ACYCLOVIR SODIUM
acyclovir sodium
INJECTABLE;INJECTION074897-002Feb 27, 1998DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: acyclovir

Country Document Number Publication Date
Hong Kong1121692Jan 15, 2010
Slovenia1998750Feb 26, 2010
Canada2647123Oct 04, 2007
South Korea101335185Dec 02, 2013
Portugal1998750Jan 08, 2010
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc